New hope for aggressive leukemia after failed prior therapy
Disease control
Recruiting now
This study is testing a new three-drug combination (tagraxofusp, azacitidine, and venetoclax) for adults newly diagnosed with a specific, aggressive form of acute myeloid leukemia (AML) that developed after their previous blood disorder treatment stopped working. The main goal is…
Phase: PHASE2 • Sponsor: Joshua Zeidner • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC